cbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
cbdMD, Inc. (YCBD) Q1 2026 Earnings Call Transcript
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results
Herbal Oasis de cbdMD se expande a Luisiana con Morales Beverage Group después de su fuerte impulso en Texas
cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
cbdMD Announces Strategic Acquisition of Bluebird Botanicals
Stock Market Today: S&P 500, Nasdaq 100 Futures Climb At The Start Of Christmas Week— Kemper, Trump Media & Technology, cbdMD In Focus
Comfort Systems, cbdMD And 3 Stocks To Watch Heading Into Monday
cbdMD, Inc. (YCBD) Q4 2025 Earnings Call Transcript
cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2025, Fourth Quarter and Fiscal Year 2025 Results
Why Are cbdMD (YCBD) Shares Surging 55% After Hours?
cbdMD, Inc. Regains Compliance with NYSE American Listing Standards
cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results
cbdMD's Herbal Oasis Hemp-Derived THC-Infused Social Seltzer Brand Expands its Product Offerings
cbdMD's Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership
cbdMD, Inc. Announces Closing of $1.7 Million Series B Preferred Private Placement
These Penny Stocks are Soaring Today: DFLI, YCBD, PSTV
cbdMD Announces Inferno Freeze: Our Most Powerful Topical
Herbal Oasis Expands Beyond the Southeast, Launches in Minnesota with Global Reserve Distribution
Herbal Oasis Expands into Tennessee with Best Brands
cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results
cbdMD Expands Oasis Social Tonics to Total Wine
Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia
cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript
cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards
cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion
cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval
cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript
cbdMD Generates $5.1 Million in Revenue, Positive Earnings
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results
cbdMD Announces It Has Fully Satisfied Its Notes
cbdMD Announces Additional Conversions of Its Convertible Notes
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
cbdMD Announces Company's CEO Joins the Board of Directors
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
cbdMD, Inc. Reschedules Earnings Release and Conference Call
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results